Overview
Study in Patients With Asthma
Status:
Completed
Completed
Trial end date:
2005-12-01
2005-12-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to determine which dose of the investigational drug is safest and most effective compared to the control drug.Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
DeyTreatments:
Formoterol Fumarate
Criteria
Inclusion Criteria:-Require regular use of an inhaled Beta-2-selective adrenergic agent
Exclusion Criteria:
- Active acute or chronic disorders of the respiratory system within one month prior to
screening
- Smoking history within the past 12 months or greater than a lifetime 10 pack-year
smoking history
- Recent surgical interventions such as lung lobectomy or resection (< one year), or
cardiothoracic interventions
- Life-threatening systemic and debilitating diseases.